On the evening of February 2nd, several listed companies disclosed their progress on share repurchases.
Midea Group (000333) had previously announced its intention to repurchase some of its issued A-shares via centralized bidding for implementing equity incentive plans and/or employee stock ownership plans. The repurchase price was set not to exceed 100 yuan per share, with a total repurchase amount between 15 billion yuan and 30 billion yuan. The implementation period is 12 months from the date the board of directors approved the repurchase plan.
The progress disclosure released by the company on the evening of February 2nd showed that, as of January 31, 2026, the company had cumulatively repurchased 26,943,700 of its A-shares through a special securities account for repurchases via centralized bidding. This represents 0.3545% of the company's current total share capital. The highest transaction price was 80.44 yuan per share, and the lowest was 69.5 yuan per share. The total amount paid was 1.998 billion yuan (excluding transaction fees). This repurchase complies with relevant laws and regulations and aligns with the company's established repurchase plan.
Similarly, S.F. Holding Co., Ltd. (002352) had previously announced its first A-share repurchase plan for 2025, which was later adjusted in October 2025. After the adjustment, the company planned a total repurchase amount of no less than 1.5 billion yuan and no more than 3 billion yuan. The shares to be repurchased are A-shares issued by the company, with a repurchase price not exceeding 60 yuan per share. The repurchase implementation period runs from April 28, 2025, to October 29, 2026.
On the evening of February 2nd, S.F. Holding disclosed that it began implementing the repurchase on September 3, 2025. As of January 31, 2026, the company had repurchased 48,288,700 A-shares via a special securities account for share repurchases using centralized bidding. The total repurchase amount was approximately 1.9 billion yuan (excluding transaction fees), representing 0.96% of the company's current total share capital. The average transaction price was 39.34 yuan per share (with a highest price of 42.23 yuan and a lowest price of 37.07 yuan).
Furthermore, Goertek (002241) had previously disclosed that, based on confidence in the company's future development and recognition of its value, and according to the company's actual situation and future needs for employee incentives, the board of directors increased the repurchase amount from no less than 500 million yuan (inclusive) and no more than 1 billion yuan (inclusive) to no less than 1 billion yuan (inclusive) and no more than 1.5 billion yuan (inclusive), with all other terms remaining unchanged.
One day later, on the evening of February 2nd, Goertek disclosed that, as of that date, the company had cumulatively repurchased 40,548,100 shares using its own funds and raised funds through a special securities account for repurchases via centralized bidding. This represents 1.14% of the company's total share capital. The highest transaction price was 34.09 yuan per share, and the lowest was 20.35 yuan per share. The total amount paid was 1.108 billion yuan (excluding transaction fees).
In addition to continuously promoting repurchases, QSII (002638) also disclosed an announcement regarding the termination of its plan to reduce holdings of repurchased shares.
In October 2025, the company had disclosed a plan to reduce its holdings of 16,498,700 repurchased A-shares, representing 1.15% of the company's total share capital, via centralized bidding between November 19, 2025, and May 19, 2026.
The announcement on the evening of February 2nd showed that, as of the disclosure date, the aforementioned plan to reduce holdings of repurchased shares had not been implemented. To stabilize the company's share price, protect shareholder interests, and enhance investor confidence, the company held its 22nd meeting of the sixth board of directors on February 2, 2026, reviewed and passed relevant proposals, and decided to terminate the aforementioned plan to reduce holdings of repurchased shares.
The push for share repurchases by listed companies is also receiving multifaceted support from financial institutions.
On the evening of February 2nd, Xidian Pharmaceutical (301130) disclosed an announcement regarding obtaining a letter of commitment for a special stock repurchase loan from a financial institution.
In January of this year, the company disclosed its intention to repurchase its issued Renminbi ordinary shares (A-shares) using own funds and/or raised funds via centralized bidding, for implementing employee stock ownership plans or equity incentives. The repurchase price per share shall not exceed 42 yuan (inclusive); the total funds shall be no less than 25 million yuan (inclusive) and no more than 50 million yuan (inclusive), with the specific total repurchase amount subject to the actual funds used upon completion of the repurchase.
Based on the upper limit of the repurchase price and the upper and lower limits of the total repurchase funds, the estimated number of shares to be repurchased is approximately 595,200 to 1,190,500, representing about 0.78% to 1.56% of the company's current total share capital. The implementation period for the share repurchase is twelve months from the date the board of directors approves this repurchase plan.
In the evening announcement on February 2nd, the company stated that it recently obtained a "Letter of Loan Commitment" issued by China Construction Bank Corporation Changchun Xi'an Dalu Sub-branch, which commits to providing special loan support for this share repurchase.
The committed loan quota is a maximum of 45 million yuan, with a loan term of 3 years. The loan purpose is for repurchasing issued and listed shares. The Letter of Loan Commitment becomes effective from the date it is signed by the legal representative or authorized agent of China Construction Bank and affixed with the bank's official seal (i.e., the date of issuance), and its validity period expires on January 29, 2027.
Comments